Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38) Elk-1 (Cavigelli et al., 1995) Hibi et al., 1993; Dérijard et al., 1994; 1 Corresponding authors 1994; Cavigelli et al., 1995; Gupta et al., 1995; Whitmarsh et al., 1995; Zinck et al., 1995) , suggesting that they may Stress-activated protein kinase-3 (SAPK3), a recently be physiological substrates for SAPK1. described MAP kinase family member with a wide-SAPK2 [also termed p38 (Han et al., 1994) , p40 spread tissue distribution, was transfected into several (Freshney et al., 1994) , RK (Rouse et al., 1994), CSBP mammalian cell lines and shown to be activated in and Mxi2 (Zervos et al., 1995)] activates response to cellular stresses, interleukin-1 (IL-1) and two protein kinases, termed MAP kinase-activated protein tumour necrosis factor (TNF) in a similar manner to kinase-2 (MAPKAP-K2, Rouse et al., 1994) , and SAPK1 (also termed JNK) and SAPK2 (also termed MAPKAP-K3 (McLaughlin et al., 1996), which share p38, RK, CSBP and Mxi2). SAPK3 and SAPK2 were 75% amino acid sequence identity, and have similar activated at similar rates in vitro by SAPKK3 (also substrate specificities in vitro (Clifton et al., 1996) . termed MKK6), and SAPKK3 was the only activator MAPKAP-K2 and MAPKAP-K3 are activated by the of SAPK3 that was induced when KB or 293 cells were same agonists as SAPK2 (Clifton et al., 1996; McLaughlin exposed to cellular stresses or stimulated with IL-1 or et al., 1996), and their activation is prevented by SB TNF. Co-transfection with SAPKK3 induced SAPK3 203580, a specific inhibitor of SAPK2 which does not activity and greatly enhanced activation in response inhibit SAPK1 or p42 and p44 MAP kinases (Cuenda to osmotic shock. These experiments indicate that et al., 1995). These observations suggest that MAPKAP-SAPKK3 mediates the activation of SAPK3 in several K2 and MAPKAP-K3 are physiological substrates of mammalian cells. SAPK3 and SAPK2 phosphorylated SAPK2. Further experiments employing SB 203580 (and a number of proteins at similar rates, including the other evidence) indicate that SAPK2 mediates the stresstranscription factors ATF2, Elk-1 and SAP1, but induced phosphorylation of the transcription factor CHOP SAPK3 was far less effective than SAPK2 in activating (at Ser78 and Ser81) which enhances its transcriptional MAPKAP kinase-2 and MAPKAP kinase-3. Unlike activity (Wang and Ron, 1996) , and that heat shock protein SAPK2, SAPK3 was not inhibited by the drug SB 27 (HSP27) (Stokoe et al., 1992a; 203580. SAPK3 phosphorylated ATF2 at Thr69, Thr71
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disrupted during cellular stress, thereby aiding cell survival Keywords: IL-1/MAP kinase kinase/MEK/stress/TNF (Lavoie et al., 1995) . The phosphorylation of CREB (at Ser133) is essential to allow this protein to stimulate the transcription of genes that contain cyclic AMP response elements (CREs). The effects of SB 203580 also indicate
Introduction.
that activation of the SAPK2-MAPKAP-K2/K3 pathway is rate limiting in the LPS-induced production of IL-1 and Two mitogen-activated protein (MAP) kinase family mem-TNF in monocytes , in the TNFbers have been identified in mammalian cells which are stimulated transcription of the genes encoding IL-6 and activated by cellular stresses (chemical, heat and osmotic granulocyte-macrophage colony-stimulating factor shock, UV radiation, inhibitors of protein synthesis), by (Beyaert et al., 1996) in fibroblasts, in the IL1-induced bacterial lipopolysaccharide (LPS) and by the cytokines stimulation of glucose uptake in epithelial cells (Gould interleukin-1 (IL-1) and tumour necrosis factor (TNF), et al., 1995) , in collagen-induced platelet aggregation and have, therefore, been termed stress-activated protein (Saklatvala et al., 1996) , in the stress-induced transcription kinases or SAPKs (reviewed in . Isoforms of the genes encoding c-Jun and c-Fos (Hazzalin et al., 1996) in fibroblasts, and in the LPS-induced synthesis of phosphorylate the transcription factors c-Jun (at Ser63 and cyclo-oxygenase-2 (COX2, the rate limiting enzyme in Ser73) (Pulverer et al., 1991) , ATF2 (at Thr69, Thr71 and Ser90) (Gupta et al., 1995; Livingstone et al., 1995) and prostaglandin synthesis) in RAW 264.7 macrophages (Paul et al., 1997) . Since the c-Fos and COX2 promoters contain separated by six amino acids from the activation loop in subdomain VIII (as compared with eight residues in CREs, the MAPKAP-K2/K3-mediated phosphorylation of CREB may contribute to the stress-and cytokine-induced SAPK1 and Ͼ12 residues in any other MAP kinase family member). The mRNA encoding SAPK3 is present in all transcription of these two genes. The importance of the CRE in the induction of c-fos mRNA is well documented rat tissues examined (Mertens et al., 1996) , the highest levels being found in skeletal muscle. Very recently, a (Ginty et al., 1994) . The transcription factors ATF2 and Elk-1 are also phosphorylated by SAPK2 in vitro and human homologue of SAPK3 was cloned and named ERK6 (Lechner et al., 1996) . Based on their finding that after transfection of mammalian cells with the upstream activators of SAPK2 that do not activate SAPK1 ERK6 mRNA was only detected in skeletal muscle and that its expression in the skeletal muscle cell line C2C12 .
The activation of SAPK1 and SAPK2 is complex, enhanced differentiation to myotubes, these investigators proposed that it may play a specialized role in this tissue because five chromatographically distinct SAP kinase kinases (SAPKKs) have been identified in mammalian (Lechner et al., 1996) . However, we have also recently cloned human SAPK3 and found its mRNA to have a cells Meier et al., 1996) . In vitro, SAPKK1 [also termed MKK4 (Dérijard et al., 1995) , wide tissue distribution (our unpublished observations), similar to our previous results in rat (Mertens et al., 1996) . SEK1 (Sanchez et al., 1994) and XMEK2 (Yashar et al., 1993) ] activates both SAPK1 (Sanchez et al., 1994;  Here, therefore, we have investigated the mechanism of activation of SAPK3 and its substrate specificity in vitro. Dérijard et al., 1995) and SAPK2 (Sanchez et al., 1994; Doza et al., 1995) , while SAPKK2 (also termed MKK3, These studies have established that SAPK3 is activated by the same stimuli that activate SAPK2 and SAPK1, and Dérijard et al., 1995) and SAPKK3 (also called MKK6, Han et al., 1996; Moriguchi et al., that SAPKK3 mediates the activation of SAPK3 in vivo as well as in vitro. The substrate specificity of SAPK3 1996; Raingeaud et al., 1996; Stein et al., 1996) activate SAPK2 but not SAPK1, and SAPKK4 and SAPKK5 overlaps with (but is distinct from) SAPK1 and SAPK2, and SAPK3 is not inhibited by SB 203580. Our results activate SAPK1 but not SAPK2 (Meier et al., 1996) . The sequences of SAPKK4/SAPKK5 are unknown. SAPKK1 raise the possibility that SAPK3, rather than SAPK1 or SAPK2, mediates the phosphorylation of transcription and SAPKK2 are the only activators of SAPK2 generated when rat pheochromocytoma (PC12) cells are exposed to factors like ATF2. chemical stress, osmotic shock, UV irradiation or the protein synthesis inhibitor anisomycin (Meier et al., 1996) .
Results
However, SAPKK3 is the dominant activator of SAPK2, and SAPKK4/SAPKK5 is/are the dominant activator(s) SAPK3 is activated by cellular stresses and cytokines of SAPK1 when human epithelial (KB) cells are exposed to the same stresses as PC12 cells or stimulated with IL-1, SAPK3 is most closely related to SAPK2, an enzyme activated by cellular stresses and the cytokines IL-1 and or when human (THP1) monocytes are stimulated with LPS Meier et al., 1996) . The identity TNF (see Introduction). We therefore investigated whether the same stimuli would activate SAPK3. Human embryof the upstream activators of SAPK1 and SAPK2 may, therefore, vary from cell to cell. onic kidney epithelial 293 cells and human epithelial KB cells were transiently transfected with a myc epitopeThe identity of the protein kinases which activate SAPKK1, SAPKK2 and SAPKK3 in vivo is unclear. At tagged SAPK3 and, after exposure to cellular stresses or cytokines, the enzyme was immunoprecipitated and least five enzymes capable of activating these SAPKKs in vitro and/or in co-transfection experiments have been assayed. These experiments showed that the stimuli which trigger the activation of SAPK2 (or SAPK1) also activate identified, namely MEK kinase (MEKK) (Yan et al., 1994; Lin et al., 1995; Matsuda et al., 1995; Blank et al., 1996) , SAPK3. Osmotic shock, the protein synthesis inhibitor anisomycin, a chemical stress (sodium arsenite), UV-C MAP kinase upstream kinase (MUK) , mixed lineage kinase-3 (MLK3) (Rana et al., 1996) , irradiation, IL-1 and TNF all activated SAPK3 5-to 14-fold ( Figure 1A and B). Similar results were obtained TGFβ-activated protein kinase-1 (TAK1) (Moriguchi et el., 1996) and the proto-oncogene Tpl2 (Salmeron et al., when SAPK3 was transiently transfected into COS-7 cells and then exposed to osmotic shock, anisomycin or sodium 1996). MEKK activates co-transfected SAPK1 more effectively than co-transfected SAPK2 or MAP kinase kinase-1 arsenite (data not shown). Epidermal growth factor (EGF) activated transfected SAPK3 more weakly, while insulin-(MKK1, a physiological activator of p42 and of 44 MAP kinases) (Xu et al., 1996) . However, SAPKK1 can also like growth factor-1 (IGF-1) and phorbol esters caused little or no activation ( Figure 1A ). In contrast, IGF-1 be activated by MUK, MLK3 and Tpl2, and SAPKK2 by TAK1, while Tpl2 can also activate MAPKK1. Further triggered a strong activation of transfected protein kinase B in parallel experiments (Alessi et al., 1996) . work is needed to understand which (if any) of these kinases activate each SAPKK in vivo under different conditions.
Identification of SAPKK3 as the major activator of SAPK3 in epithelial cells Recently, a novel MAP kinase family member was cloned in one of our laboratories (Mertens et al., 1996) .
Lysates from 293 cells that had been osmotically shocked for 15 min were chromatographed on Mono S and assayed This enzyme is most similar to SAPK2 (60% identity) and SAPK1 (47% identity) and, therefore, was called for activators of SAPK2 and SAPK3. As reported previously for other mammalian cells ; SAPK3. Like SAPK2, SAPK3 contains a TGY motif in the activation domain (which is TPY in SAPK1 and TEY Meier et al., 1996) , two peaks of SAPK2 activator were identified. The first eluted at the same position as SAPKK1 in p42 and p44 MAP kinases) and subdomain VII is and SAPKK3 and the second at the same position as SAPKK2. Neither peak was observed in control experiments using lysates from unstimulated cells ( Figure 2A ). The first peak of activity was SAPKK3 (or a very closely related homologue), because it was immunoprecipitated quantitatively by anti-MKK6 antibodies, but not by anti-MKK4 or anti-MKK3 antibodies ( Figure 2B ). The second peak was immunoprecipitated by anti-MKK3 antibodies, but not by anti-MKK4 or anti-MKK6 antibodies ( Figure  2B ). When the same fractions were assayed for activators of SAPK3, only a single peak was detected which co-eluted with SAPKK3 ( Figure 2C ) and was immunoprecipitated by anti-MKK6, but not by anti-MKK4 or anti-MKK3 antibodies ( Figure 2D ). Identical results were obtained when the cells were stimulated with anisomycin (data not shown). No SAPK3 activator was observed in control experiments using lysates from unstimulated cells ( Figure 2C ).
We have shown previously that SAPKK3 accounts for 95-100% of the SAPK2 activator detected after Mono S chromatography of lysates from KB cells that have been stressed in several ways or stimulated with IL-1 Meier et al., 1996) . As shown in Figure 3 , the single peak of SAPK3 activator detected after subjecting KB cells to osmotic shock or anisomycin comigrated with SAPKK3 on Mono S and was immunoprecipitated quantitatively and specifically by anti-MKK6 antibodies. This experiment also demonstrated that SAPKK4 and SAPKK5, which are also activated in KB cells by these stimuli, and which elute from Mono S at a higher NaCl concentration than SAPKK3 (Meier et al., 1996) , do not activate SAPK3.
Further evidence that SAPKK3 can activate SAPK3 in vivo was obtained by co-transfection into COS cells. These experiments showed that SAPK3 activity was elevated 10-fold by co-expression with SAPKK3, and that exposure to osmotic shock triggered a 30-fold greater activation of transfected SAPK3 in cells where SAPKK3 had been co-transfected ( Figure 4 ).
Activation of SAPK3 by SAPKK3 in vitro
SAPK3 was activated in vitro by a highly purified preparation of SAPKK3 from skeletal muscle ( Figure 5 ), but could not be activated by MKK1 under conditions where p42 MAP kinase was activated maximally (data not shown). The rate of activation of SAPK3 by SAPKK3 was similar to that of SAPK2, and both enzymes attained Figure 5A and B). The activity of transfected with a DNA construct expressing a myc epitope-tagged SAPK2 and SAPK3 towards MBP is 25-to 50-fold lower SAPK3. Cells in DMEM were stimulated for 15 min with 0.5 M than the activity of p42 MAP kinase towards this substrate sorbitol (an osmotic shock), 20 ng/ml IL-1α, 100 ng/ml TNFα, 0.5 mM sodium arsenite (a chemical stress), 100 ng/ml of EGF or (Stokoe et al., 1992b) . No activation or phosphorylation 300 ng/ml TPA, for 30 min with 10 μg/ml anisomycin or 10 min with of SAPK2 or SAPK3 occurred when SAPKK3 was inactiv- became phosphorylated at a serine residue(s). This did not occur when wild-type SAPK3 was replaced by an inactive mutant ( Figure 5D ), suggesting that serine . The fractions were assayed for activators of SAPK2 (A) or SAPK3 (C) as described in Materials and methods. The broken line shows the NaCl gradient. Similar results were obtained in three different experiments. The two major SAPK2 activators from (A) (I and II) were pooled separately and immunoprecipitated using anti-MKK6 antibodies, anti-MKK4 antibodies or anti-MKK3 antibodies. In (B), the amount of SAPK2 activator remaining in the supernatant is shown and in (D) the amount of SAPK3 activator remaining in the supernatant after immunoprecipitation in the presence (ϩ) or absence (-) of the appropriate competing peptide immunogen (0.6 mM) is shown relative to control incubations (100%) where antibody was omitted. The results presented are the average Ϯ SEM for three separate experiments.
phosphorylation is an autophosphorylation event catalysed p53, while c-Jun was only poorly phosphorylated by by SAPK3 itself after it has been activated. The site of both enzymes (Table I) . SAPK1 has been shown to autophosphorylation is likely to be at Ser3 and/or Ser281, phosphorylate ATF2 at Thr69, Thr71 and Ser90 which are the only two serine residues in SAPK3 that are (Livingstone et al., 1995) and the phosphorylation of followed by proline (Mertens et al., 1996) .
ATF2 by SAPK2 and SAPK3 was therefore studied in greater detail using wild-type ATF2 and mutants in which Activation of SAPK3 by SAPKK1(MKK4) in vitro these residues had been changed to Ala. Phosphoamino SAPK2 is not only phosphorylated by SAPKK2 and acid analysis showed that, after phosphorylation by SAPKK3 in vitro, but also by SAPKK1 (MKK4) (see SAPK3, wild-type ATF2 was phosphorylated on threonine Introduction). SAPKK1 is itself activated by cytokines and serine residues, the phosphothreonine content being and cellular stresses and it was of interest, therefore, to twice as high as the phosphoserine content (data not investigate whether this enzyme had the potential to shown). In contrast, after phosphorylation by SAPK2, activate SAPK3 in vitro. Figure 6 shows that SAPK3 can ATF2 was only phosphorylated on threonine (data not be activated by SAPKK1 in vitro, but the initial rate of shown). Consistent with these experiments, a mutant ATF2 activation of SAPK3 is much slower than that of SAPK2 in which Thr69 and Thr71 were changed to alanine was under identical conditions ( Figure 6 ). Consistent with this phosphorylated by SAPK3, but not by SAPK2 (Figure 7 ) slow rate of activation, SAPK3, like SAPK2, was not and phosphorylation of this mutant by SAPK3 occurred activated after co-transfection in COS-1 cells with MEK only on serine (data not shown). A mutant ATF2, in which kinase (Figure 4) , an upstream activator of SAPKK1. This Thr69, Thr71 and Ser90 were all changed to Ala, was not is consistent with the negligible contribution of SAPKK1 phosphorylated by either SAPK2 or SAPK3, and a mutant to the total SAPK3-activating activity observed in KB and in which Ser90 was changed to Ala was phosphorylated COS cells.
at threonine residues by both SAPK2 and SAPK3 ( Figure  7) . These experiments indicate that SAPK2 and SAPK3 Comparison of the substrate specificities of SAPK2 phosphorylate ATF2 at Thr69 and Thr71, and that only and SAPK3 SAPK3 phosphorylates Ser90. SAPK3 was just as active as SAPK2 in phosphorylating the transcription factors Elk-1, ATF2, SAP1, SAP2 and SAPK3 was far less effective than SAPK2 in activat- MAPKAP-K3 by SAPK2 was similar to that of MBP under the same conditions used in Figure 1 . Although SAPK3 was a much poorer activator of MAPKAP-K2 and MAPKAP-K3 than SAPK2, the initial rate of phosphorylation of MAPKAP-K2 and MAPKAP-K3 by SAPK3 was only 2-to 3-fold slower than by SAPK2. This implies that, like p42 MAP kinase, SAPK3 can phosphorylate sites on MAPKAP-K2 and MAPKAP-K3 that do not cause activation SAPK3 is not inhibited by SB 203580 SAPK3 that had been expressed in Escherichia coli and activated by SAPKK3 (Figure 9 ), or myc epitope-tagged In this study, we demonstrate that SAPK3 is activated in before (d) and after (n) immunoprecipitation of SAPKK3.
response to the same cellular stresses and cytokines as SAPK1 and SAPK2. In two epithelial cell lines, the only activator of SAPK3 that could be detected was SAPKK3, ing GST-MAPKAP-K2(46-400) and full-length GST-MAPKAP-K3, the initial rate of activation of MAPKAPthe product of the MKK6 gene that we have shown previously to be the dominant activator of SAPK2 in K2 and MAPKAP-K3 and the half-time for maximal activation being 20 times slower ( Figure 8A and B) . We extracts prepared from monocytes and muscle, as well as epithelial cells . SAPKK3 activated have reported previously that p42 MAP kinase can activate GST-MAPKAP-K2(46-400) in vitro, but cannot activate SAPK3 and SAPK2 at similar rates in vitro. Moreover, the stress-induced activation of SAPK3 was greatly a nearly full-length MAPKAP-K2 [GST-MAPKAP-K2(5-400)] (Ben- Levy et al., 1995) . SAPK3 was also unable to enhanced by co-expression with SAPKK3. These observations indicate that SAPKK3 mediates the activation of activate GST-MAPKAP-K2(5-400) significantly ( Figure  8C ).
SAPK3 by cellular stresses and cytokines in epithelial cells. SAPK3 was not activated at a significant rate by The rate of phosphorylation of MAPKAP-K2 and ) the Xenopus homologue of SAPK2 (MalE-Mpk2, 0.5 μM) were incubated with unlabelled MgATP and 100 U/ml SAPKK3 and the generation of activity (d) measured at the times indicated using MBP as substrate. No activation of either GST-SAPK3 or MalE-Mpk2 occurred when SAPKK3 was first inactivated with PP2A (s). Phosphorylation of GST-SAPK3 or MalE-Mpk2 (n) was determined in parallel incubations using [γ-32 P]ATP (10 6 c.p.m. per nmol) and in (C) the 15 and 120 min time points from (A) and (B) were partially hydrolysed for 90 min in 6 M HCl at 110°C, electrophoresed on thin layer cellulose at pH 3.5 and autoradiographed to identify phosphoserine (pS), phosphothreonine (pT) and phosphotyrosine (pY). (D) Same as the 120 min time point in (C), except that wild-type SAPK3 was replaced by a 'kinase-inactive' mutant in which Asp171 was changed to Ala. Figure 5 ) and phosphorylation of each protein studied at a SAPK concentration of 0.1 U/ml. Fig. 6 . Activation of SAPK3 and SAPK2 by SAPKK1 (MKK4). GST-SAPK3 (0.5 μM, s) or a MalE fusion protein of the Xenopus homologue of SAPK2 (0.5 μM, d) was incubated with unlabelled stress and cytokine-induced activation of MAPKAP-K2 MgATP and 100 U/ml SAPKK1 and the generation of activity measured at the times indicated using MBP as substrate. and MAPKAP-K3 by 80-95% in every mammalian cell examined so far Beyaert et al., 1996; Clifton et al., 1996; McLaughlin et al., 1996) . MKK1, SAPKK1 (MKK4), SAPKK2 (MKK3), SAPKK4 or SAPKK5.
Despite the differences between SAPK3 and SAPK2 outlined above, these enzymes phosphorylated a number Although the amino acid sequence of SAPK3 is 60% identical to SAPK2, and both enzymes share the TGY of proteins in vitro at similar rates (Table I) , including the transcription factor ATF2. ATF2 has been suggested to be phosphorylation motif and a six amino acid insertion between subdomain VII and the activation loop in suba physiogical substrate of SAPK1 and SAPK2, since it is phosphorylated in cells co-transfected with SAPKK1, domain VIII (see Introduction), the properties of SAPK3 differed from SAPK2 in several respects. Firstly, SAPK3 MEKK (an upstream activator of SAPKK1) or SAPKK3 (see Introduction). However, transfection with upstream was not inhibited by SB 203580 (Figure 9 ). Secondly, SAPK3 but not SAPK2 phosphorylated ATF2 at Ser90 activators may not mimic the in vivo situation, for example by generating abnormally high levels of SAPK1 and (Figure 7) . Thirdly, SAPK3 was far less effective than SAPK2 in activating MAPKAP-K2 and MAPKAP-K3, SAPK2 activity. Moreover, the present work has raised another problem in the interpretation of these experiments consistent with the finding that SB 203580 suppresses the by demonstrating that SAPKK3 activates SAPK3 as well SAPK1 and SAPK2, because it becomes phosphorylated in cells that have been co-transfected with SAPKK1, as SAPK2. Further experiments employing SB 203580 are essential, therefore, to evaluate whether SAPK2 or MEKK or SAPKK3 (see Introduction). These experiments are subject to the same reservations as outlined above for SAPK3 mediates the phosphorylation of ATF2 triggered by transfection with SAPKK3. However, even if SB ATF2, but a further caveat with Elk-1 is that it is also an effective substrate for p42 and p44 MAP kinases which 203580 prevents the phosphorylation of ATF2 induced by transfection with SAPKK3, it is unlikely that SAPK2 are activated by several of the stresses and cytokines that activate SAPKs. Elk-1 (like SAP1 and SAP2) is an Ets activity is rate limiting for ATF2 phosphorylation in vivo, because neither the TNF-induced (Beyaert et al., 1996) domain protein and a member of the TCF family of transcription factors that form ternary complexes with the nor the stress-induced (Hazzalin et al., 1996) phosphorylation of the endogenous ATF2 in fibroblastic cell lines is serum response factor (SRF) and bind to the serum response element (SRE) found in the promoters of a affected by SB 203580 under conditions where this drug prevents the activation of MAPKAP-K2 and the induction number of genes including c-Fos. The induction of c-fos mRNA in response to anisomycin or UV irradiation is of IL-6 and c-fos mRNA. Further work is needed to clarify whether the phosphorylation of ATF2 occurring under largely suppressed by SB 203580 in C3HT101/2 fibroblasts (Hazzalin et al., 1996) , while in HeLa cells and NIH 3T3 these conditions is catalysed by SAPK1, SAPK3 or another (as yet unidentified) SAPK.
cells the induction of c-Fos induced by UV irradiation was partially inhibited by SB 203580 and by PD 98059 SAPK3 and SAPK2 phosphorylated the transcription factor Elk-1 at similar rates (Table I) and, like ATF2,
[a specific inhibitor of the activation of MKK1 (Alessi et al., 1995a) ] and almost completely suppressed in the Elk-1 has been suggested to be a physiogical substrate of presence of both inhibitors (Price and Treisman, 1996 ). These observations demonstrate that SAPK2 activity is rate limiting in the transcriptional activation of the c-fos gene and that the activation of both SAPK2 and ERK1/ ERK2 contributes to the induction of c-fos mRNA in UVirradiated cells. However, whether the suppression of c-fos mRNA production by SB 203580 results from inhibition of the phosphorylation of Elk-1 or another TCF like SAP1 or SAP2, or by preventing the MAPKAP-K2-mediated phosphorylation of CREB (see Introduction), has not yet been established. The phosphorylation of Elk-1 induced by co-transfection with MEKK was prevented by PD rylation of Elk-1 under these conditions. Earlier reports were matched for activity against MBP and each enzyme (0.4 U/ml) had claimed that SAPK1 was activated specifically when incubated for 30 min at 30°C with 1 μM wild-type (WT) or mutant cells were transfected with low levels of MEKK DNA and Mg[γ-32 P]ATP in a total volume of 50 μl. The reactions were stopped by adding 5 μl of 6% (by mass) SDS and the (Minden et al., 1994) , but the effects of PD 98059 (which samples electrophoresed on 10% SDS-polyacrylamide gels and has no effect on the activation of SAPK1; Alessi et al., autoradiographed. Abbreviations: T69T71, mutant in which Thr69 and 1995a; Price and Treisman, 1996) indicate that this is not Thr71 were mutated to Ala; T69T71S90, mutant in which Thr69, the case. Taken together, the results of Price and Treisman Thr71 and Ser90 were mutated to Ala; S90, mutant in which Ser90 was mutated to Ala.
(1996) indicate that neither SAPK1 nor SAPK3 are rate , and various derivatives of in which Thr69, Thr71 and/or Ser90 were mutated to Ala (Drs N.Jones and R.Treisman, ICRF, London). MalE fusion proteins expressing the C-terminal kinase domain of MEK kinase (MalE-MEKK) and the Xenopus homologue of SAPK2 (MalE-Mpk2) were generous gifts from Dr A.R.Nebreda (EMBL, Heidelberg, Germany). DNA expressing the C-terminal kinase domain of MEK kinase for transfection studies (Olson et al., 1995) was provided by Dr A.Ashworth (Institute of Cancer Research, London). p53 (Helps et al., 1995) was provided by Dr N.Helps in the MRC Protein Phosphorylation Unit.
SAPK3 and SAPKK3 expression plasmids
For bacterial expression, the open reading frame (ORF) of cDNA clone rSAPK37 (Mertens et al., 1996) was amplified by PCR and subcloned as an EcoRI fragment into expression vector pGEX-4T1 (Pharmacia), followed by transformation into E.coli strain BL21 (DE3). The transformed bacteria were grown to an absorbance of 0.6 at 600 nm and induced with 0.4 mM isopropyl-1-thio-β-galactopyranoside (IPTG). Fig. 9 . Effect of SB 203580 on the activity of SAPK3 and SAPK2. Bacterially expressed SAPK3 (s) and SAPK2 (d) were activated GST-SAPK3 was purified by affinity chromatography on glutathioneagarose. For transfections, the ORF of cDNA clone rSAPK37 was in vitro with purified SAPKK3 ( Figure 5 ) and then assayed in the presence of the indicated concentrations of SB 203580. The results are amplified by PCR and subcloned as an EcoRI fragment into the mammalian expression vector pSG5 (Stratagene). Alternatively, PCR presented relative to control incubations in which the inhibitor was omitted.
was used to introduce a nucleotide sequence encoding the c-myc tag MEQKLISEEDLN at the carboxy-terminus of rSAPK3, followed by a stop condon. The resulting fragment was then ligated into pSG5. A bacterial expression construct encoding human SAPKK3 (Cuenda et al., limiting for the phosphorylation of Elk-1 and induction 1996) was a kind gift from Dr A.R.Nebreda. The ORF of human of c-fos mRNA in UV-irradiated HeLa cells. The develop-SAPKK3 was amplified by PCR and subcloned as a HindIII fragment ment of specific inhibitors of the activity or activation of into the mammalian expressing plasmid pcDNA3.1 (Invitrogen). Substi-SAPK1 and SAPK3 will be needed to elucidate the tution of Asp171 by Ala in SAPK3 to produce a kinase-inactive mutant was performed by site-directed mutagenesis. PCR fragments were verified physiological roles of these enzymes.
by DNA sequencing.
While this manuscript was in preparation, the amino acid sequence of a novel MAP kinase homologue was Cell culture and transient transfections reported (Jiang et al., 1996) . This enzyme, called p38β, KB, 293 and COS-7 cells were cultured in Dulbecco's modified Eagle's is 74% identical to SAPK2. Transfected p38β was activated Medium (DMEM) supplemented with 10% fetal calf serum (FCS), at 37°C, in an atmosphere of 5% CO 2 . Transfections of 293 cells were in response to IL-1, TNF or stresses and appeared to carried out using the calcium phosphate method. Cells were split to a be a relatively specific substrate of SAPKK3 (MKK6). density of 2ϫ10 6 per 10 cm dish and, after 12 h at 37°C, 10 μg of Moreover, when activated, it was able to phosphorylate plasmid DNA in 0.45 ml of sterile water was added to 50 μl of sterile 
Materials and methods
24 h at 37°C in an atmosphere of 5% CO 2 , the cells were washed once with 2 ml of serum-free growth medium, and 2 μg of DNA (previously Materials Tissue culture reagents, microcystin-LR, Lipofectin reagent, MBP and incubated for 15 min at room temperature with 15 μg of lipofectin reagent) was added. After 6 h at 37°C in an atmosphere of 5% CO 2 , the human IGF-1 were purchased from Gibco-BRL (Paisley, UK), protein G-Sepharose from Pharmacia (Milton Keynes, UK), and recombinant DNA-containing medium was replaced with new DMEM containing 10% FCS. After a further 48 h, the cells were stimulated with the human IL-1α and EGF from Boehringer; anisomycin, sorbitol and TNFα from Sigma (Poole, UK). PKI, the specific peptide inhibitor of cAMPagonists indicated in the figure legends. Cells were incubated in DMEM for 12 h in the absence of serum before stimulation with IGF-1 or for dependent protein kinase (TTYADFIASGRTGRRNAIHD) and all other peptides were synthesized by Mr F.B.Caudwell in the MRC Protein 1 h before exposure to other stimuli. Cells were lysed as described (Rouse et al., 1994) , except that 2 μM microcystin was present in the Phosphorylation Unit. SB 203580, a generous gift from Dr J.Lee (SmithKline Beecham, King of Prussia, USA), was dissolved in dimethyllysis buffer. sulfoxide to give a final concentration of 20 mM. Other reagents were of analytical grade or better, and purchased from BDH Chemicals or Protein kinase assays SAPK3 was assayed routinely by the phosphorylation of MBP. SAPK3 Sigma Chemical Co. (Poole, UK).
(0.5 or 1 μM) in 40 μl of 25 mM Tris-HCl pH 7.5, 0.1 mM EGTA, 0.1 mM sodium orthovanadate, 1 μM PKI and 0.33 mg/ml MBP was Enzymes and transcription factors SAPKK3 was purified from rabbit skeletal muscle . incubated for 3 min at 30°C before initiating the reaction with 10 μl of 50 mM magnesium acetate-0.5 mM [γ-32 P]ATP. After 20 min at 30°C, The E.coli plasmids encoding glutathione S-transferase (GST) fusion proteins were kindly provided by the investigators shown in parentheses, 40 μl aliquots were withdrawn, spotted on to 1.5ϫ1.5 cm squares of Whatman P81 phosphocellulose paper and immersed in 75 mM phosexpressed in E.coli and purified by affinity chromatography on glutathione-agarose: GST-MAPKAP-K2(5-400) and GST-MAPKAP-K2 phoric acid. After washing and drying the papers (Alessi et al., 1995b) , Fig. 10 . Schematic representation of mammalian MAP kinase and SAP kinase signal transduction pathways. Following growth factor or phorbol ester stimulation, the MAP kinase kinases MAPKK1 and MAPKK2 (also termed MEK1 and MEK2) activate the ERK1 and ERK2 group of MAP kinases. ERK1 and ERK2 (also termed p44 and p42 MAP kinases, respectively) phosphorylate a number of substrates, including the protein kinase MAPKAP-K1 (also termed p90 rsk ) and the transcription factor Elk-1. SAP kinase (SAPK) pathways are activated by proinflammatory cytokines and a number of stressful stimuli. The SAP kinase kinase SAPKK1 (also termed MKK4 and SEK1) activates SAPK1 (also termed SAPK or JNK) which phosphorylates the transcription factor c-Jun. SAPKK2 (also termed MKK3) activates SAPK2A (also termed p38, RK, CSBP and Mxi2), which phosphorylates the protein kinases MAPKAP-K2 and MAPKAP-K3, as well as the transcription factors CHOP and Elk-1. The SAP kinase kinase SAPKK3 (also termed MKK6) activates SAPK2A, SAPK2B (also termed p38β) and SAPK3 (also termed ERK6). Studies with the specific inhibitor SB 203580 indicate that SAPK2A (and perhaps SAPK2B) phosphorylate the protein kinases MAPKAPK-2 and MAPKAPK-3, as well as the transcription factors CHOP and Elk-1. The reason why ATF2 is an unlikely physiological substrate for SAPK2A and SAPK2B is given in the text, and this transcription factor may therefore be phosphorylated by SAPK1 and/or SAPK3 in vivo. SAPKK1 activates SAPK2A and SAPK2B in vitro and in co-transfection experiments, but is not thought to activate these enzymes in vivo. Question marks indicate that a given SAPK phosphorylates a target protein in vitro, with no current evidence for a corresponding role in vivo.
32 P radioactivity incorporated into MBP was measured. One unit of
Immunoprecipitation of SAPK3
Lysates of cells transfected with SAPK3 were centrifuged at 4°C for activity was that amount of enzyme which incorporated 1 nmol of 10 min at 13 000 g. Aliquots of the supernatant (100 μg protein) were phosphate into MBP in 1 min.
incubated for 120 min on a shaking platform with 5 μl of protein G-SAPK3 activators were assayed by their ability to activate GSTSepharose coupled to either 3 μg of 9E10 monoclonal antibody which SAPK3. A 15 μl Mono S fraction was incubated for 3 min at 30°C with recognizes the myc epitope (for myc-epitope tagged SAPK3) or 5 μg of 2.5 μl of 10 μM GST-SAPK3 in 50 mM Tris-HCl pH 7.5, 0.1 mM affinity-purified polyclonal antibody raised in sheep against the EGTA, 0.03% (by mass) Brij-35, 0.1% (by vol.) 2-mercaptoethanol and C-terminal sequence of rat SAPK3 (KPPRNLGARVPKETAL) (for 5% (by vol.) glycerol, and the reaction was initiated with 2.5 μl of untagged SAPK3). The suspension was centrifuged for 1 min at 13 000 g, 80 mM magnesium acetate-0.8 mM unlabelled ATP. After 30 min, an and the pellet washed twice with 1 ml of lysis buffer containing 0.5 M aliquot (10 μl) was withdrawn and assayed for SAPK3 activity as NaCl, and twice with lysis buffer, and the immunoprecipitate assayed described above. Control experiments were carried out in which GSTfor SAPK3 activity as described above, except that the reactions were SAPK3 was omitted from the incubation mixture. One unit of SAPK3 carried out on a shaking platform to ensure that the agarose beads activator was that amount which increased the activity of SAPK3 by remained in suspension and therefore had access to the substrate. 1 U/min.
MAPKAP-K2 and MAPKAP-K3 were assayed using the peptide Antibodies and immunoprecipitation of SAPKKs KKLNRTLSVA as substrate (Stokoe et al., 1993) and one unit of activity Polyclonal anti-MKK3 antibodies (raised against the peptide RNLDSRwas that amount which catalysed the phosphorylation of 1 nmol of TFITIGDRN corresponding to a sequence near the N-terminus of MKK3), peptide substrate in 1 min. SAPK2 was measured by the activation of anti-MKK4 antibodies (raised against the peptide EQMPVSPSSPMYVD GST-MAPKAP-K2(46-400) and SAPK2 activators by their ability to corresponding to the C-terminal 14 residues of XMEK2) and antiactivate MalE-Mpk2 (the Xenopus homologue of SAPK2) (Meier MKK6 antibodies (raised against the peptide CNPGLKEAFEQPQTS et al., 1996) . corresponding to a sequence near the N-terminus of human MKK6) were generated and purified as described previously (Cuenda et al., Activation and stoichiometric phosphorylation of 1996; Meier et al., 1996) . Aliquots (30 μl) of Mono S-purified SAPK2 GST-SAPK3 and MalE-Mpk2 by SAPKK3 and SAPKK1 activators or SAPK3 activator were incubated at 4°C on a shaking The incubations contained 25 mM Tris-HCl, pH 7.5, 0.1 mM EGTA, platform with 5 μl of protein G-Sepharose coupled to 5 μg of anti-1 μM PKI, 0.1% (by vol.) 2-mercaptoethanol, 0.5 μM GST-SAPK3 or MKK3, 5 μl of anti-MKK4 or 2 μg of anti-MKK6 antibodies. After MalE-Mpk2, purified SAPKK3 or SAPKK1 (100 U/ml, see Cuenda mixing for 90 min, the suspensions were centrifuged for 2 min at 13 000 g and the supernatants assayed for SAPK3 activator. In control et al., 1996 for definition of units), 10 mM magnesium acetate and experiments, antibodies bound to protein G-Sepharose were incubated 0.1 mM ATP. The reaction was initiated with MgATP after pre-incubating for 30 min at 4°C with 50 nmol of the appropriate peptide immunogen the other components for 3 min at 30°C. At various times, aliquots were prior to immunoprecipitation. removed and assayed for SAPK3 or SAPK2 activity as described above. To determine the extent of phosphorylation of SAPK3 and SAPK2, parallel incubations were carried out in which unlabelled ATP was
